Literature DB >> 11103387

Desire for information about drugs. A multi-method study in general medical inpatients.

K Aström1, J Carlsson, I Bates, D G Webb, C Duggan, P Sanghani, D McRobbie.   

Abstract

The purpose of this paper is to investigate patients' drug information preferences using a combination of quantitative and qualitative methods. Patient interviews (n = 299) were conducted on general medical wards in three London teaching hospitals. The purpose was to refine and validate a quantitative 12-item scale, the Intrinsic Desire for Information (IDI), by interfacing quantitative and qualitative data, and to explore the relationship between this scale score and patient demographics. The IDI-scale was subjected to factor analysis. Two secondary factors were found in the IDI scale; a 5-item factor describing the extent of information desired and a weaker 3-item factor describing an inhibited desire for knowledge about illness/drugs. Reliability analysis and multiple regression analysis were undertaken. Responses to open answer questions during the qualitative interviews were transcribed at the bedside and imported into QSR NUD*IST software program for coding and analysis. The methodology employed in this study involved importing quantitative, summative data into a qualitative data base and re-analysing both the quantitative and qualitative data to validate the scale. Age was a predominant factor associated with patient desire for information, although the data suggest that educational and socio-economic status are also influential. Factor 1, the extent of information desired, may have value in targeting receptive patients, or in identifying those who may be refractory to drug information. The refined tool could help health services to effectively target information provision based on evidence, rather than supposition.

Entities:  

Mesh:

Year:  2000        PMID: 11103387     DOI: 10.1023/a:1008783115420

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  9 in total

1.  Preventable drug-related morbidity in community pharmacy: commentary on the implications for practice and policy of a novel intervention.

Authors:  Mara Pereira Guerreiro; Ana Paula Martins; Judith Anne Cantrill
Journal:  Int J Clin Pharm       Date:  2012-07-10

2.  Desire for information about drugs: a survey of the need for information in psychiatric in-patients.

Authors:  Lieven Zwaenepoel; Rita Bilo; Willy De Boever; Marc De Vos; Johan Reyntens; Vera Hoorens; Walter Sermeus; Gert Laekeman
Journal:  Pharm World Sci       Date:  2005-02

3.  Desire for information about drugs: relationships with patients' characteristics and adverse effects.

Authors:  R Laaksonen; C Duggan; I Bates
Journal:  Pharm World Sci       Date:  2002-10

4.  Drug information in psychiatric hospitals in Flanders: a study of patient-oriented leaflets.

Authors:  Lieven Zwaenepoel; Gert Laekeman
Journal:  Pharm World Sci       Date:  2003-12

5.  The value of inpatient pharmaceutical counselling to elderly patients prior to discharge.

Authors:  S A Al-Rashed; D J Wright; N Roebuck; W Sunter; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

6.  Communicating medication risk to cardiovascular patients in Qatar.

Authors:  Kerry Wilbur; Arwa Sahal; Dina Elgaily
Journal:  Int J Health Care Qual Assur       Date:  2018-02-12

7.  Validation of a survey tool for use in cross-cultural studies.

Authors:  Filipa A Costa; Catherine Duggan; Ian Bates
Journal:  Pharm Pract (Granada)       Date:  2008-09-15

8.  Evaluation of medication counseling practice at community pharmacies in Qassim region, Saudi Arabia.

Authors:  Abubakr A Alfadl; Alian A Alrasheedy; Musaad S Alhassun
Journal:  Saudi Pharm J       Date:  2017-12-05       Impact factor: 4.330

9.  Patients' perceptions of medicines information received at hospital discharge in Norway: a qualitative interview study.

Authors:  K Svensberg; E Trapnes; D Nguyen; R A Hasan; J K Sund; L Mathiesen
Journal:  Int J Clin Pharm       Date:  2020-08-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.